Todhunter et al. encircling IL-13R2-targeted therapies in pre-clinical and clinical study, including potential strategies to improve IL-13R2-directed cancer treatment efficacy. receptor modulation/signaling, and variety of strategies available for selective targeting. Interleukin-13 receptor subunit alpha-2 (IL-13R2) is PD98059 usually a high-affinity membrane receptor for the anti-inflammatory cytokine interleukin 13 (IL-13). IL-13R2 Continue Reading